BridgeMD
New treatment option for Spinal Muscular Atrophy (SMA)
Official title Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
ClinicalTrials.gov ID: NCT07321977
What this study is testing
- What it's testing
- In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- All volunteers
- Age between 18 and 65
- Ambulatory
- Informed consent to participate in the study
- Member of or beneficiary of a social security system
You likely can't join if
- All volunteers
- Individuals under guardianship, curatorship, or legal protection
- Pregnant or breastfeeding women
- Non-ambulatory individuals
- Individuals with epilepsy
- Skin conditions preventing the placement of VICON motion sensors
See the full eligibility criteria
- All volunteers
- Age between 18 and 65
- Ambulatory
- Informed consent to participate in the study
- Member of or beneficiary of a social security system
- Volunteers with a neuromuscular disease
- Confirmed diagnosis of a neuromuscular disease of genetic origin (medical document to be provided upon enrollment in the study with proof of diagnosis) belonging to the list above.
- Ability to walk for 2 minutes without assistance.
- Ability to stand up from a chair with armrests at least 3 times in 30 seconds.
- Ability to climb an inclined plane independently or with assistance to access the movement analysis room.
- All volunteers
- Individuals under guardianship, curatorship, or legal protection
- Pregnant or breastfeeding women
- Non-ambulatory individuals
- Individuals with epilepsy
- Skin conditions preventing the placement of VICON motion sensors
- Asymptomatic volunteers
- Unstable respiratory or cardiac problems
- Neurological, musculoskeletal, or psychiatric problems
- Volunteers with a neuromuscular disease
- Recent trauma or serious falls (≤ 6 months)
- Individuals who have fallen more than twice in the past year and at least once in the past three months
- Use of assistive devices such as rigid knee braces or walkers
- Unstable cardiomyopathy
- Individuals awaiting diagnosis Exclusion criteria
- Inability to comply with the protocol requirements
- Medical or social conditions that could interfere with the study, as determined by the coordinating investigator or co-investigators.
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.